UpHealth, Inc. reaffirmed earnings guidance for fiscal 2022. For the full year 2022, the Company continues to expect total revenue between $205 and $233 million, a 38-56% growth rate, gross margins of 42% to 43% and adjusted EBITDA of $14 to $19 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.525 USD | -0.91% | -4.49% | +128.76% |
03-21 | UpHealth, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
03-21 | UpHealth, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+128.76% | 9.88M | |
-9.51% | 24.65B | |
+16.46% | 22.18B | |
-0.56% | 2.29B | |
+100.79% | 2.12B | |
-24.90% | 1.86B | |
-45.27% | 1.71B | |
+3.51% | 1.3B | |
-18.38% | 1.26B | |
-3.47% | 1.24B |
- Stock Market
- Equities
- UPHL Stock
- News UpHealth, Inc.
- UpHealth, Inc. Reaffirms Earnings Guidance for Fiscal 2022